Vitamin-based Asthma Therapeutics: 1α,25-dihydroxyvitamin D(3) inhibits asthma pathogenesis via down regulation of its target gene, 21/August/2014, 05.48 am

Insights into the treatment of Myocardial Infarction: Myogenin protects infarcted heart via up regulation of its target gene, 21/August/2014, 05.39 am
August 21, 2014
AntagomiR-based therapy for Hepatic Steatosis: MiRNA-138 aggravates hepatic steatosis via down regulation of its target gene, 21/August/2014, 06.00 am
August 21, 2014
Show all

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

Citation: Boominathan, L., Vitamin-based Asthma Therapeutics1α,25-dihydroxyvitamin D(3) inhibits asthma pathogenesis via down regulation of its target gene, 21/August/2014, 05.53 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Web: http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org.

*Research cooperation

 Significance:  This study suggests that 1α,25-dihydroxyvitamin D(3), by suppressing the expression of its target gene, it may up regulate the expression of a gene that is required to inhibit asthma pathogenesis.  Together, this study suggests that pharmacological formulations encompassing “1α,25-dihydroxyvitamin D(3) or its analogues” may be used to treat patients suffering from severe asthma. 

Comments are closed.